| Product Code: ETC12320133 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Hormone Refractory Prostate Cancer Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Hormone Refractory Prostate Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 China Hormone Refractory Prostate Cancer Market - Industry Life Cycle |
3.4 China Hormone Refractory Prostate Cancer Market - Porter's Five Forces |
3.5 China Hormone Refractory Prostate Cancer Market Revenues & Volume Share, By Cancer Stage, 2021 & 2031F |
3.6 China Hormone Refractory Prostate Cancer Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 China Hormone Refractory Prostate Cancer Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 China Hormone Refractory Prostate Cancer Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 China Hormone Refractory Prostate Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of prostate cancer in China |
4.2.2 Advancements in medical research leading to the development of new treatment options |
4.2.3 Growing awareness and adoption of targeted therapies for hormone refractory prostate cancer |
4.3 Market Restraints |
4.3.1 High cost associated with advanced treatment options |
4.3.2 Limited access to specialized healthcare facilities in certain regions of China |
4.3.3 Stringent regulatory requirements for approval of new therapies |
5 China Hormone Refractory Prostate Cancer Market Trends |
6 China Hormone Refractory Prostate Cancer Market, By Types |
6.1 China Hormone Refractory Prostate Cancer Market, By Cancer Stage |
6.1.1 Overview and Analysis |
6.1.2 China Hormone Refractory Prostate Cancer Market Revenues & Volume, By Cancer Stage, 2021 - 2031F |
6.1.3 China Hormone Refractory Prostate Cancer Market Revenues & Volume, By Castration-resistant Prostate Cancer, 2021 - 2031F |
6.1.4 China Hormone Refractory Prostate Cancer Market Revenues & Volume, By Metastatic Hormone-refractory Cancer, 2021 - 2031F |
6.1.5 China Hormone Refractory Prostate Cancer Market Revenues & Volume, By Non-metastatic Hormone-refractory Cancer, 2021 - 2031F |
6.1.6 China Hormone Refractory Prostate Cancer Market Revenues & Volume, By Recurrent Prostate Cancer, 2021 - 2031F |
6.2 China Hormone Refractory Prostate Cancer Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 China Hormone Refractory Prostate Cancer Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.2.3 China Hormone Refractory Prostate Cancer Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.2.4 China Hormone Refractory Prostate Cancer Market Revenues & Volume, By Androgen Receptor Inhibitors, 2021 - 2031F |
6.2.5 China Hormone Refractory Prostate Cancer Market Revenues & Volume, By Radioisotope Therapy, 2021 - 2031F |
6.3 China Hormone Refractory Prostate Cancer Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 China Hormone Refractory Prostate Cancer Market Revenues & Volume, By Men Aged 50+, 2021 - 2031F |
6.3.3 China Hormone Refractory Prostate Cancer Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.3.4 China Hormone Refractory Prostate Cancer Market Revenues & Volume, By Urology Clinics, 2021 - 2031F |
6.3.5 China Hormone Refractory Prostate Cancer Market Revenues & Volume, By Cancer Research Institutes, 2021 - 2031F |
6.4 China Hormone Refractory Prostate Cancer Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 China Hormone Refractory Prostate Cancer Market Revenues & Volume, By Late-stage Cancer Treatment, 2021 - 2031F |
6.4.3 China Hormone Refractory Prostate Cancer Market Revenues & Volume, By Advanced Prostate Cancer Care, 2021 - 2031F |
6.4.4 China Hormone Refractory Prostate Cancer Market Revenues & Volume, By Localized Prostate Cancer, 2021 - 2031F |
6.4.5 China Hormone Refractory Prostate Cancer Market Revenues & Volume, By Precision Oncology, 2021 - 2031F |
7 China Hormone Refractory Prostate Cancer Market Import-Export Trade Statistics |
7.1 China Hormone Refractory Prostate Cancer Market Export to Major Countries |
7.2 China Hormone Refractory Prostate Cancer Market Imports from Major Countries |
8 China Hormone Refractory Prostate Cancer Market Key Performance Indicators |
8.1 Patient survival rate post-treatment |
8.2 Adoption rate of new targeted therapies |
8.3 Percentage of healthcare providers offering specialized care for hormone refractory prostate cancer |
8.4 Research and development investment in innovative treatment options |
8.5 Patient satisfaction and quality of life post-treatment |
9 China Hormone Refractory Prostate Cancer Market - Opportunity Assessment |
9.1 China Hormone Refractory Prostate Cancer Market Opportunity Assessment, By Cancer Stage, 2021 & 2031F |
9.2 China Hormone Refractory Prostate Cancer Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 China Hormone Refractory Prostate Cancer Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 China Hormone Refractory Prostate Cancer Market Opportunity Assessment, By Application, 2021 & 2031F |
10 China Hormone Refractory Prostate Cancer Market - Competitive Landscape |
10.1 China Hormone Refractory Prostate Cancer Market Revenue Share, By Companies, 2024 |
10.2 China Hormone Refractory Prostate Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here